Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.77
+0.10 (1.30%)
At close: Jan 17, 2025, 4:00 PM
8.00
+0.23 (2.96%)
Pre-market: Jan 21, 2025, 8:49 AM EST
Aura Biosciences Employees
As of December 31, 2023, Aura Biosciences had 89 total employees, including 88 full-time and 1 part-time employees. The number of employees increased by 17 or 23.61% compared to the previous year.
Employees
89
Change (1Y)
17
Growth (1Y)
23.61%
Revenue / Employee
n/a
Profits / Employee
-$935,011
Market Cap
388.12M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 89 | 17 | 23.61% |
Dec 31, 2022 | 72 | 20 | 38.46% |
Dec 31, 2021 | 52 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AURA News
- 7 weeks ago - Muscle Invasive Bladder Cancer Drug Pipeline Market Research 2024 Featuring Aura Biosciences, Janssen Research & Development, Asieris Pharmaceuticals, and RemeGen - GlobeNewsWire
- 3 months ago - Aura Biosciences: 2 Positive Bel-Sar Data Releases Brings Shareholder Value - Seeking Alpha
- 3 months ago - Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease - Benzinga
- 3 months ago - Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial - GlobeNewsWire
- 3 months ago - 3 Small-Cap Stocks Ready to Deliver Significant Growth - Benzinga
- 4 months ago - Sept. 13-20 Undercovered Stock Picks: Aura Biosciences, APA Corporation, iTeos, CuriosityStream + - Seeking Alpha
- 4 months ago - Aura Biosciences: Highly Derisked Late-Stage Eye Cancer Company - Seeking Alpha
- 4 months ago - Aura Biosciences Touts Promising Data From Eye Cancer Candidate - Benzinga